Zapraszamy na wykład Prof. Davida Kavanagha z NRCTC – National Complement Terapeutics Centre z Newcastle oraz dr Ewy Elenberg z Texas Childrens Hospital z Houston.
| 11:10–11:40 | Complement in health and disease | Prof. David Kavanagh, Newcastle, UK |
| 11:40–12:10 | The English experience in treatment of aHUS with eculizumab | Prof. David Kavanagh, Newcastle, UK |
| 12:30–12:50 | Atypical hemolytic-uremic syndrome in children – the American experience | dr Ewa Elenberg, Houston, Texas |